Joshua Boverman is a Psychiatry physician affiliated with City College of New York. OpenAlex indexes 10 publications with 400 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Portland, OR 972393011
Telephone
503-494-6176Registry record last updated 8 Jul 2007.
Clinical trials
- Medications for the Treatment of Dysthymic Disorder and Double Depression
Sponsor: Oregon Health and Science University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
97.9%Atypical Antipsychotic35.9%Olanzapine35%Clozapine26%Quetiapine Fumarate11%Risperidone5%Lurasidone Hcl4%Rexulti4%Invega Sustenna4%Ziprasidone Hcl4%Paliperidone Er3%Versacloz3%Part D<11 patientsBenzodiazepine12.1%Clonazepam54%Lorazepam46%Part D<11 patients+ 16 more classes in this area
Hormonal (systemic)
2.1%l-Thyroxine2.1%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Opioid-Prescribing Practices and Provider Confidence Recognizing Opioid Analgesic Abuse in HIV Primary Care Settings
JAIDS Journal of Acquired Immune Deficiency Syndromes
2011 - Improved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV Clinics
JAIDS Journal of Acquired Immune Deficiency Syndromes
2011 - Improving Adherence to HIV Quality of Care Indicators in Persons With Opioid Dependence: The Role of Buprenorphine
JAIDS Journal of Acquired Immune Deficiency Syndromes
2011 - Patients' Reasons for Choosing Office-Based Buprenorphine: Preference for Patient-Centered Care
Journal of Addiction Medicine
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Mini Kamboj, MD
City College of New York
Alison Pack, MD
City College of New York
Alisen Huang, MD
City College of New York
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”